Medical Composition Containing Stauntonia Hexaphylla Extract

摘要

#$%^&*AU2016201841B220171102.pdf#####ABSTRACT OF THE DISCLOSURE Disclosed is an antipyretic drug comprising a Stauntonia Hexaphylla leaf extract as an active ingredient. 5 The antipyretic drug is developed based on the finding that the Stauntonia Hexaphylla leaf extract has no cytotoxicity and exhibits superior antipyretic effects, as compared to conventional antipyretic drugs having antipyretic effects. An antipyretic composition comprising the Stauntonia 0 Hexaphylla leaf extract as an active ingredient exhibits potent antipyretic effect.